Lantern Pharma
LTRN
LTRN
25 hedge funds and large institutions have $10.4M invested in Lantern Pharma in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $21K
Holders
25
Holding in Top 10
–
Calls
–
Puts
$21K
Top Buyers
| 1 | +$342K | |
| 2 | +$302K | |
| 3 | +$241K | |
| 4 |
Renaissance Technologies
New York
|
+$77K |
| 5 |
JPMorgan Chase & Co
New York
|
+$19.7K |
Top Sellers
| 1 | -$519K | |
| 2 | -$399K | |
| 3 | -$387K | |
| 4 |
Two Sigma Investments
New York
|
-$352K |
| 5 |
Morgan Stanley
New York
|
-$274K |